CANC

Exchange-traded product on NASDAQ (US)

Type
Exchange-traded product
Share class
—
Status
listed
ISIN
—
Currency
—
Represents the company
No

Holdings as of Aug 31, 2026

59 lines, 56 linked, weights sum to 100.05% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
Revolution Medicines Inc RVMD US76155X1000 Equity 61,768 −24,682 6.02% $ 12.698M
Eli Lilly & Co LLY US5324571083 Equity 9,404 +1,720 5.15% $ 10.878M
Cogent Biosciences Inc COGT US19240Q2012 Equity 283,440 +77,021 4.70% $ 9.92M
Roche Holding AG
RHHBY US7711951043 Equity 164,068 +22,415 4.17% $ 8.81M
Novartis AG
NOVN CH0012005267 Equity 52,465 +5,445 3.79% $ 8M
Bristol-Myers Squibb Co BMY US1101221083 Equity 112,924 +11,244 3.57% $ 7.544M
Merck & Co Inc MRK US58933Y1055 Equity 50,878 −2,100 3.56% $ 7.518M
AbbVie Inc ABBV US00287Y1091 Equity 27,338 +4,638 3.32% $ 7.01M
Halozyme Therapeutics Inc HALO US40637H1095 Equity 63,165 +30,567 3.19% $ 6.726M
BeOne Medicines Ltd ONC US07725L1026 Equity 18,669 +7,164 3.18% $ 6.713M
Johnson & Johnson JNJ US4781601046 Equity 24,555 +4,655 3.09% $ 6.528M
Immunome Inc IMNM US45257U1088 Equity 230,958 −84,690 3.00% $ 6.331M
Genmab A/S GMAB US3723032062 Equity 183,357 +24,496 2.88% $ 6.08M
CG oncology Inc CGON US1569441009 Equity 77,547 +8,845 2.76% $ 5.828M
Ideaya Biosciences Inc IDYA US45166A1025 Equity 142,271 +6,424 2.70% $ 5.705M
Exelixis Inc EXEL US30161Q1040 Equity 101,461 +4,576 2.63% $ 5.544M
Bridgebio Pharma Inc BBIO US10806X1028 Equity 64,261 −8,930 2.33% $ 4.922M
Amgen Inc AMGN US0311621009 Equity 10,097 −922 2.06% $ 4.34M
Enliven Therapeutics Inc ELVN US29337E1029 Equity 74,478 +16,281 2.04% $ 4.312M
AstraZeneca PLC AZN GB0009895292 Equity 25,983 −7,518 2.00% $ 4.214M
Legend Biotech Corp LEGN US52490G1022 Equity 197,934 +3,842 1.95% $ 4.113M
Zai Lab Ltd ZLAB US98887Q1040 Equity 161,278 −35,694 1.95% $ 4.106M
Celcuity Inc CELC US15102K1007 Equity 42,837 −4,613 1.81% $ 3.815M
Erasca Inc ERAS US29479A1088 Equity 208,197 +60,369 1.76% $ 3.723M
Relay Therapeutics Inc RLAY US75943R1023 Equity 185,142 +24,066 1.61% $ 3.403M
Iovance Biotherapeutics Inc IOVA US4622601007 Equity 403,718 +123,670 1.56% $ 3.298M
Zymeworks Inc ZYME US98985Y1082 Equity 110,609 +4,994 1.54% $ 3.253M
Nuvation Bio Inc NUVB US67080N1019 Equity 416,638 +21,325 1.31% $ 2.775M
UroGen Pharma Ltd URGN IL0011407140 Equity 61,279 +2,761 1.25% $ 2.641M
Arcus Biosciences Inc RCUS US03969F1093 Equity 87,067 +3,927 1.21% $ 2.549M
Kura Oncology Inc KURA US50127T1097 Equity 171,385 new +171,385 1.03% $ 2.168M
Gilead Sciences Inc GILD US3755581036 Equity 14,646 −46 1.02% $ 2.143M
Tyra Biosciences Inc TYRA US90240B1061 Equity 85,323 +69,543 1.01% $ 2.136M
Summit Therapeutics Inc SMMT US86627T1088 Equity 150,035 +28,938 0.97% $ 2.043M
Corvus Pharmaceuticals Inc CRVS US2210151005 Equity 142,722 +34,245 0.95% $ 2.004M
Natera Inc NTRA US6323071042 Equity 6,084 +1,846 0.93% $ 1.959M
Tango Therapeutics Inc TNGX US87583X1090 Equity 81,952 new +81,952 0.89% $ 1.872M
AnaptysBio Inc ANAB US0327241065 Equity 32,744 +1,474 0.88% $ 1.867M
Immatics NV IMTX NL0015285941 Equity 179,617 +8,118 0.81% $ 1.712M
Replimune Group Inc REPL US76029N1063 Equity 108,413 new +108,413 0.79% $ 1.659M
Immunocore Holdings PLC IMCR US45258D1054 Equity 44,900 +14,051 0.77% $ 1.631M
Cullinan Therapeutics Inc CGEM US2300311063 Equity 65,785 +2,959 0.69% $ 1.452M
Guardant Health Inc GH US40131M1099 Equity 8,773 −2,213 0.66% $ 1.395M
ORIC Pharmaceuticals Inc ORIC US68622P1093 Equity 99,043 +41,066 0.61% $ 1.287M
Candel Therapeutics Inc CADL US1374041093 Equity 86,337 new +86,337 0.53% $ 1.128M
Syndax Pharmaceuticals Inc SNDX US87164F1057 Equity 54,962 −17,250 0.50% $ 1.06M
Janux Therapeutics Inc JANX US47103J1051 Equity 53,953 +2,431 0.47% $ 983.024K
Inhibrx Biosciences Inc INBX US45720N1037 Equity 7,084 −3,086 0.43% $ 897.543K
Olema Pharmaceuticals Inc OLMA US68062P1066 Equity 83,532 +3,773 0.41% $ 871.239K
Bicara Therapeutics Inc BCAX US0554771032 Equity 37,499 new +37,499 0.41% $ 866.977K
BridgeBio Oncology Therapeutic BBOT US1079241022 Equity 97,750 +4,411 0.41% $ 860.2K
CytomX Therapeutics Inc CTMX US23284F1057 Equity 241,337 +12,350 0.38% $ 810.892K
Arvinas Inc ARVN US04335A1051 Equity 88,095 +3,971 0.38% $ 810.474K
First American Treasury Obliga
FXFXX US31846V3289 Money market 807,908.68 −1,112,400.27 0.38% $ 807.909K
First Tracks Biotherapeutics I TRAX US3371851029 Equity 19,205 −39,214 0.38% $ 803.537K
Moderna Inc MRNA US60770K1079 Equity 5,247 new +5,247 0.35% $ 736.364K
Adlai Nortye Group Ltd ANL US00704R1095 Equity 46,444 +2,090 0.31% $ 659.04K
ArriVent Biopharma Inc AVBP US04272N1028 Equity 21,729 −21,015 0.31% $ 652.956K
Autolus Therapeutics PLC AUTL US05280R1005 Equity 268,127 new +268,127 0.30% $ 630.098K